A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer

Shivaani Kummar, M. Sitki Copur, Michal Rose, Scott Wadler, Joe Stephenson, Mark O'Rourke, Wayne Brenckman, Robert Tilton, Shwu Huey Liu, Zaoli Jiang, Tahmun Su, Yung Chi Cheng, Edward Chu

Research output: Contribution to journalArticlepeer-review

86 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences